Welcome to the ValueWiki ISOTECHNIKA INC. (ISA:CA) article! Register for free or click the "edit" link to contribute!

ISOTECHNIKA INC. (ISA:CA)

From ValueWiki

Jump to: navigation, search

Launch Chat Window

TSX \ Life Sciences \ Biotechnology & Pharmaceuticals

ISOTECHNIKA INC. is a biopharmaceutical company. The company is primarily focused on the development of immunosuppressive drugs for use in the treatment of autoimmune diseases and the prevention of organ rejection in transplantation.Summary from Toronto Stock Exchange

1 Company Analysis
2 News Feed
3 Risks
4 Research Links
5 Notes

Today

Max

[edit]

Company Analysis

You can add your own information here - just click the blue edit tab. Or view examples at the Start a new article page.

The edit window has shortcut and help links if you need them.^[1] Be bold!

[edit]

News Feed

11/26/08 8:11 am	Isotechnika's Partner Receives European Medicines Agency Acceptance of its Pediatric Investigation Plan for LUVENIQ(TM) (voclosporin) (CNW Group)
11/14/08 9:11 am	Isotechnika reports third quarter financial results (CNW Group)
11/03/08 10:11 am	Isotechnika selected to present at the American Society of Nephrology conference (CNW Group)
10/16/08 10:10 am	Isotechnika partner invited to present on drug eluting stent trial using voclosporin (CNW Group)